View Older Stories View More Recent Stories

Mar 6, 2018 08:00AM GBT Appoints Industry Leader David L. Johnson as Chief Commercial Officer
Mar 5, 2018 04:05PM GBT Announces Participation at Upcoming Investor Conferences in March
Mar 5, 2018 04:05PM GBT Announces New Employment Inducement Grants
Feb 27, 2018 04:07PM GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2017 Financial Results
Feb 7, 2018 04:05PM GBT Announces Participation at the Leerink Partners 7th Annual Global Healthcare Conference
Jan 23, 2018 09:23AM Pre-Open Movers 01/23: (RGSE) (CNET) (NFLX) Higher; (GPRO) (ADMS) (TWTR) Lower (more...)
Jan 9, 2018 08:03AM Global Blood Therapeutics (GBT) Announces FDA Breakthrough Therapy Designation for Voxelotor for Treatment of SCD
Jan 9, 2018 08:00AM GBT Receives FDA Breakthrough Therapy Designation for Voxelotor for Treatment of Sickle Cell Disease (SCD)
Jan 3, 2018 04:05PM GBT to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 22, 2017 09:00AM GBT Appoints Wendy L. Yarno to Board of Directors
Dec 11, 2017 07:14AM Global Blood Therapeutics (GBT) Announces Presentation of Six Studies at ASH Supporting Voxelotor SCD Program
Dec 11, 2017 07:00AM GBT Announces Presentation of Six Studies at ASH Supporting Voxelotor Sickle Cell Disease (SCD) Program
Dec 11, 2017 05:42AM Global Blood Therapeutics (GBT) Presents New Phase 2a Data at ASH for Voxelotor in Adolescents with Sickle Cell Disease
Dec 9, 2017 10:00AM GBT Announces New Phase 2a Data at ASH for Voxelotor in Adolescents with Sickle Cell Disease (SCD)
Nov 30, 2017 04:05PM Global Blood Therapeutics Announces New Employment Inducement Grants
Nov 13, 2017 08:13AM Global Blood Therapeutics (GBT) Announces Completion of Safety Review by Independent DSMB for Phase 3 HOPE Study in SCD
Nov 13, 2017 08:00AM Global Blood Therapeutics Announces Completion of Safety Review by Independent Data and Safety Monitoring Board (DSMB) for Phase 3 HOPE Study in Sickle Cell Disease
Nov 7, 2017 04:05PM Global Blood Therapeutics Announces Participation at the Stifel 2017 Healthcare Conference
Nov 2, 2017 04:05PM Global Blood Therapeutics Reports Recent Business Progress and Provides Third Quarter 2017 Financial Results
Nov 1, 2017 09:00AM Global Blood Therapeutics Announces Upcoming Data Presentations Supporting Sickle Cell Disease Program at 59th American Society of Hematology (ASH) Annual Meeting
Oct 28, 2017 02:15PM Global Blood Therapeutics Announces Presentation of Case Study Demonstrating Positive Effect of Voxelotor (GBT440) in a Sickle Cell Disease Patient with Severe and Symptomatic Anemia
Oct 24, 2017 08:00AM Global Blood Therapeutics Announces Approval of First-in-Class “Voxelotor” as Nonproprietary Name for GBT440
Oct 23, 2017 07:02AM Global Blood Therapeutics (GBT) to Discontinue GBT440 Program for Treatment of IPF
Oct 23, 2017 07:00AM Global Blood Therapeutics Announces Discontinuation of Idiopathic Pulmonary Fibrosis (IPF) Program
Oct 11, 2017 08:04AM Global Blood Therapeutics (GBT) Announces Presentation of New Data Showing Positive Effect of GBT440 on SCD Patient with Variant Genotype
Oct 11, 2017 08:00AM Global Blood Therapeutics Announces Presentation of New Data Showing Positive Effect of GBT440 on Sickle Cell Disease Patient with Variant Genotype
Oct 3, 2017 08:00AM Global Blood Therapeutics Announces Upcoming Presentations of GBT440 Data at Two Sickle Cell Disease Meetings in October
Sep 26, 2017 04:05PM Global Blood Therapeutics Announces New Employment Inducement Grants
Sep 6, 2017 08:00AM Global Blood Therapeutics To Convene Sickle Cell Disease Influencers at Annual Sickle Cell Disease (SCD) Therapeutics Conference
Sep 5, 2017 08:02AM Global Blood Therapeutics (GBT) Announces Rare Pediatric Disease Designation from FDA for GBT440 for Treatment of SCD
Sep 5, 2017 08:00AM Global Blood Therapeutics Receives Rare Pediatric Disease Designation from FDA for GBT440 for Treatment of Sickle Cell Disease (SCD)
Aug 30, 2017 04:05PM Global Blood Therapeutics Announces Upcoming Participation in Multiple Investor Conferences in September
Aug 9, 2017 04:05PM Global Blood Therapeutics Announces Participation at the 2017 Wedbush PacGrow Healthcare Conference
Aug 7, 2017 04:05PM Global Blood Therapeutics Reports Recent Business Progress and Provides Second Quarter 2017 Financial Results
Jul 26, 2017 04:05PM Global Blood Therapeutics Announces New Employment Inducement Grants
Jul 10, 2017 08:06AM Global Blood Therapeutics (GBT) Expands Phase 2a HOPE-KIDS 1 Study into Younger Pediatric
Jul 10, 2017 08:00AM Global Blood Therapeutics Expands Ongoing Phase 2a HOPE-KIDS 1 Study into Younger Pediatric Population
Jun 28, 2017 08:03AM Global Blood Therapeutics (GBT) Receives EMA PRIME Designation for GBT440 for Treatment of SCD
Jun 28, 2017 08:00AM Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)
Jun 23, 2017 05:39AM Global Blood Therapeutics (GBT) Reports New Data Supporting Ongoing Clinical Development of GBT440 in Adolescents with Sickle Cell Disease
Jun 23, 2017 02:30AM Global Blood Therapeutics Announces New Data Supporting Ongoing Clinical Development of GBT440 in Adolescents with Sickle Cell Disease
Jun 6, 2017 04:05PM Global Blood Therapeutics Announces Participation at the Goldman Sachs 38th Annual Global Healthcare Conference
May 18, 2017 04:15PM Global Blood Therapeutics (GBT) Announces Upcoming Presentation of GBT440 Data in Adolescents with Sickle Cell Disease at EHA
May 18, 2017 04:00PM Global Blood Therapeutics Announces Upcoming Presentation of GBT440 Data in Adolescents with Sickle Cell Disease at European Hematology Association’s 22nd Congress
May 1, 2017 04:05PM Global Blood Therapeutics Reports Recent Business Progress and Provides First Quarter 2017 Financial Results
Mar 29, 2017 04:05PM Global Blood Therapeutics to Present at the 16th Annual Needham Healthcare Conference
Mar 13, 2017 04:05PM Global Blood Therapeutics Reports Recent Business Progress and Fourth Quarter and Year-End 2016 Financial Results
Mar 1, 2017 04:05PM Global Blood Therapeutics Announces Participation at Two Upcoming Investor Conferences in March
Aug 13, 2015 10:00AM Global Blood Therapeutics, Inc. (Nasdaq: GBT) to Ring The Nasdaq Stock Market Opening Bell
Aug 13, 2015 10:00AM Global Blood Therapeutics, Inc. (Nasdaq: GBT) to Ring The Nasdaq Stock Market Opening Bell
View More Recent Stories View Older Stories